PMSFF: Improved Protein Binding Residues Prediction through Multi-Scale Sequence-Based Feature Fusion Strategy
Biomolecules · 27.09.2024 · 14 (10) · 1220
DOI: 10.3390/biom14101220 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomolecules, online erschienen am 27.09.2024. Verfasst von Yuguang Li und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Computer and Artificial Intelligence, Zhengzhou University, Zhengzhou 450001, China. Hauptthemen laut MEDLINE: Proteins, Protein Binding. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 96 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Major Science and Technology Projects in Henan Province, General Project of National Natural Science Foundation of China.
Abstract (Originalsprache)
Proteins perform different biological functions through binding with various molecules which are mediated by a few key residues and accurate prediction of such protein binding residues (PBRs) is crucial for understanding cellular processes and for designing new drugs. Many computational prediction approaches have been proposed to identify PBRs with sequence-based features. However, these approaches face two main challenges: (1) these methods only concatenate residue feature vectors with a simple sliding window strategy, and (2) it is challenging to find a uniform sliding window size suitable for learning embeddings across different types of PBRs. In this study, we propose one novel framework that could apply multiple types of PBRs Prediciton task through Multi-scale Sequence-based Feature Fusion (PMSFF) strategy. Firstly, PMSFF employs a pre-trained language model named ProtT5, to encode amino acid residues in protein sequences. Then, it generates multi-scale residue embeddings by applying multi-size windows to capture effective neighboring residues and multi-size kernels to learn information across different scales. Additionally, the proposed model treats protein sequences as sentences, employing a bidirectional GRU to learn global context. We also collect benchmark datasets encompassing various PBRs types and evaluate our PMSFF approach to these datasets. Compared with state-of-the-art methods, PMSFF demonstrates superior performance on most PBRs prediction tasks.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Computer and Artificial Intelligence, Zhengzhou University, Zhengzhou 450001, China.
- School of Life Sciences, Zhengzhou University, Zhengzhou 450001, China.
- Longhu Laboratory of Advanced Immunology, Zhengzhou 450001, China.
- National Supercomputing Center in Zhengzhou, Zhengzhou University, Zhengzhou 450001, China.
- Yangtze Delta Region Institute (Quzhou), University of Electronic Science and Technology of China, Quzhou 324003, China.
ORCID-Profile: Xiaofei Nan, Shuai Lu, Zhen Tian
Förderung
- National Natural Science Foundation of China
- Major Science and Technology Projects in Henan Province
- General Project of National Natural Science Foundation of China
- Key Research and Development Projects in Henan Province
- Natural Science Foundation of Henan Province of China
Zitieren
APA
Li, Y., Nan, X., Zhang, S., Zhou, Q., Lu, S., & Tian, Z. (2024). PMSFF: Improved Protein Binding Residues Prediction through Multi-Scale Sequence-Based Feature Fusion Strategy. Biomolecules, 14(10), 1220. https://doi.org/10.3390/biom14101220
Vancouver
Li Y, Nan X, Zhang S, Zhou Q, Lu S, Tian Z. PMSFF: Improved Protein Binding Residues Prediction through Multi-Scale Sequence-Based Feature Fusion Strategy. Biomolecules. 2024;14(10):1220. doi:10.3390/biom14101220
BibTeX
@article{Li2024,
author = {Li, Yuguang and Nan, Xiaofei and Zhang, Shoutao and Zhou, Qinglei and Lu, Shuai and Tian, Zhen},
title = {PMSFF: Improved Protein Binding Residues Prediction through Multi-Scale Sequence-Based Feature Fusion Strategy},
journal = {Biomolecules},
year = {2024},
volume = {14},
number = {10},
pages = {1220},
doi = {10.3390/biom14101220}
}
EUVIMED